Trial intelligence / Profile preview

Ferric Carboxymaltose +/- EPO in Hip Fracture

NCT01154491Phase 3Completed

Sponsor
Fundación Pública Andaluza para la Gestión de la Investigación
Start
Jun 2010
Primary completion
May 2013
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferric carboxymaltose, erythropoietin in anemia, sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Jun 2010; status: completed.

02

Drugs

ferric carboxymaltoseerythropoietin
03

Conditions

anemia

Beyond the preview

Go deeper on NCT01154491.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01154491.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call